4
Changes in Ownership
RxSight, Inc. Filed Acc 0000950170-24-012317
Chief Financial Officer sold 25,000 shares at an average $47.31 ($1,182,660)
- Chief Financial Officer acquired 31,900 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Thunen Shelley B Chief Financial Officer | 2024-02-05 | Option exercise | +6,900 | $4.34 | $29,946 | 13,691 | D |
| Thunen Shelley B Chief Financial Officer | 2024-02-05 | Option exercise | +9,125 | $14.95 | $136,419 | 22,816 | D |
| Thunen Shelley B Chief Financial Officer | 2024-02-05 | Sale | −9,125 | $47.02 | $429,087 | 13,691 | D |
| Thunen Shelley B Chief Financial Officer | 2024-02-06 | Option exercise | +15,875 | $14.95 | $237,331 | 29,566 | D |
| Thunen Shelley B Chief Financial Officer | 2024-02-06 | Sale | −15,875 | $47.47 | $753,574 | 13,691 | D |
| Derivatives | |||||||
| Thunen Shelley B Chief Financial Officer | 2024-02-05 | Option exercise · Stock Option (right to buy) | −6,900 | 17,640 | D | ||
| Thunen Shelley B Chief Financial Officer | 2024-02-05 | Option exercise · Stock Option (right to buy) | −9,125 | 110,875 | D | ||
| Thunen Shelley B Chief Financial Officer | 2024-02-06 | Option exercise · Stock Option (right to buy) | −15,875 | 95,000 | D | ||
| Open-market sales · 25,000 sh · avg $47.31 · $1,182,660 | |||||||
Loading xslF345X05/ownership.xml…